For laboratory research only · Not for human or veterinary use

Skip to content
A 10 mg Thymosin Alpha-1 vial: clear glass with a silver crimped cap, labelled Thymosin Alpha-1 10MG, peptide research, research use only.
Lot NVE-2444-BVerified

Thymosin Alpha-1

Tα1 · Thymalfasin

Each vial contains 10 mg of Thymosin Alpha-1.

Thymosin Alpha-1 is a synthetic twenty-eight-amino-acid peptide corresponding to a thymic hormone. What the clinical literature examines, how far it got, and where the molecule is approved are set out under How it works below.

  • Lyophilized powder, requires reconstitution
Vial size

Price

$70.00 CAD

In stock

Produced & shipped in Canada

Specification

CAS number
62304-98-7
Molecular formula
C129H215N33O55
Molecular weight
3,108.3 g/mol
Purity
≥ 98.7% by RP-HPLC
Form
Lyophilized powder
Third-party assay
Purity and fill
Origin
Canada
Storage
-20 °C, protected from light
Lot
NVE-2444-B

How it works

The literature here is organised by the clinical questions this peptide was put to rather than by a receptor it was characterised at, which is unusual for this catalog. What follows is those questions, and how far each of them got.

  • T-cell and dendritic-cell signalling

    The laboratory question

    Signalling in T cells and dendritic cells is the account the research offers of what the peptide does in culture. It is the proposed mechanism the literature argues about, and it is not settled in either direction.

  • Chronic hepatitis B and C

    Where most of the clinical work is

    Human studies in chronic hepatitis B and in chronic hepatitis C make up much of the clinical literature. Those are the conditions the trials enrolled; an enrolled condition is not an indication for material sold here.

  • Sepsis

    Critical-care trials

    Examined in critical-care trials in sepsis. That is a body of trials of varying quality conducted largely outside North America, and reading it as a settled answer is the error this page is written against.

  • Vaccine adjuvant

    A separate line of study

    Studied as an adjuvant alongside vaccines — a question about what happens when it accompanies something else, which is a different question from what it does alone.

Where the evidence stands

Human trial data exists, of varying quality and largely from outside North America. The molecule is approved as a medicine in some countries, and not in Canada or the United States. Material on this page is research material, not an approved medicine.

Working-solution calculator

Laboratory results

Opened as the laboratory issued them, unedited. Every certificate we publish

Research use only

Supplied as a laboratory research chemical. Not a drug, food or cosmetic, and not for human or veterinary use. No application guidance is provided or implied.